Filter
325
Filtered Results: 325
Text search:
mRNA
Featured
Recommendations
62
New Publications
9
Language
Document type
Guidelines
103
Fact sheets
65
Studies & Reports
43
No document type
37
Videos
29
Manuals
13
Resource Platforms
11
Strategic & Response Plan
9
Training Material
5
Infographics
5
Situation Updates
3
Brochures
1
Online Courses
1
Countries / Regions
Germany
23
Brazil
17
Russia
12
Global
11
Ukraine
9
Latin America and the Carribbean
9
Middle East and North Africa
7
India
7
South Africa
5
Ecuador
5
Syria
4
Nigeria
4
Argentina
4
Yemen
4
Senegal
3
Mozambique
3
Africa
3
Lebanon
3
Eastern Europe
3
China
2
Kazakhstan
2
Chile
2
Niger
2
Peru
2
Haiti
2
Western and Central Europe
2
Belarus
2
Uganda
2
Sudan
2
Mali
2
South Sudan
2
Somalia
2
Colombia
1
Kenya
1
Mexico
1
El Salvador
1
Benin
1
Sierra Leone
1
Rwanda
1
Cameroon
1
Congo-Brazzaville
1
Burkina Faso
1
Morocco
1
Qatar
1
Mauritania
1
Dominican Republic
1
Venezuela
1
Jordan
1
Saudi Arabia
1
Congo, Democratic Republic of
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Nicaragua
1
Egypt
1
Ethiopia
1
Honduras
1
Angola
1
Chad
1
Libya
1
Indonesia
1
Iraq
1
Liberia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
103
Clinical Guidelines
21
Public Health
8
Key Resources
8
Women & Child Health
4
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
COVID-19
206
Refugee
22
HIV
9
TB
9
Rapid Response
6
Mental Health
6
Conflict
5
Ebola
4
NTDs
4
Pharmacy
3
Health Financing Toolbox
3
NCDs
2
Specific Hazards
1
Planetary Health
1
Zika
1
Global Health Education
1
AMR
1
Orientaciones provisionales
9 de agosto de 2021
El presente documento tiene por objeto describir un conjunto mínimo de actividades de vigilancia recomendadas a nivel nacional para detectar y supervisar la prevalencia relativa de las variantes del SRAS-CoV-2 y esbozar un conjunto de actividades pa...
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related to coadministration of Covid-19 and influenza vacc...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
Der Verein Medizin Hilft e.V. aus Berlin hat eine Informationsbroschüre zum Thema Corona-Impfung in mehreren Sprachen erstellt
Deutsch, Englisch, Französisch, Serbisch, Türkisch, Arabisch, Farsi, Vietnamese
National Operationalisation Plan for the COVID-19 Vaccine : 13th edition
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
5 April 2022, Addendum. This policy brief confirms WHO guidance and policy on injection safety in the context of the extraordinary increase in global injections resulting from COVID-19 immunization campaigns. It also calls attention to information on specialized syringes for COVID-19 vaccines and br...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Updated Treatment Guidelines
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
Tips and guidelines for the care of pregnant women and newborns in the context of the pandemic. ( version 16 June 2021)
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
